Neutrophil to lymphocyte ratio predicts cardiovascular events in people with type 2 diabetes: Post hoc analysis of the SUSTAIN 6 and PIONEER 6 cardiovascular outcomes trials

Publikation: Bidrag til tidsskriftLetterForskningfagfællebedømt

Standard

Neutrophil to lymphocyte ratio predicts cardiovascular events in people with type 2 diabetes : Post hoc analysis of the SUSTAIN 6 and PIONEER 6 cardiovascular outcomes trials. / Verma, Subodh; Husain, Mansoor; Madsen, Christian M.; Leiter, Lawrence A.; Kuhlman, Anja Birk; Vilsbøll, Tina; Rasmussen, Søren; Libby, Peter.

I: Diabetes, Obesity and Metabolism, Bind 25, Nr. 8, 2023, s. 2398-2401.

Publikation: Bidrag til tidsskriftLetterForskningfagfællebedømt

Harvard

Verma, S, Husain, M, Madsen, CM, Leiter, LA, Kuhlman, AB, Vilsbøll, T, Rasmussen, S & Libby, P 2023, 'Neutrophil to lymphocyte ratio predicts cardiovascular events in people with type 2 diabetes: Post hoc analysis of the SUSTAIN 6 and PIONEER 6 cardiovascular outcomes trials', Diabetes, Obesity and Metabolism, bind 25, nr. 8, s. 2398-2401. https://doi.org/10.1111/dom.15088

APA

Verma, S., Husain, M., Madsen, C. M., Leiter, L. A., Kuhlman, A. B., Vilsbøll, T., Rasmussen, S., & Libby, P. (2023). Neutrophil to lymphocyte ratio predicts cardiovascular events in people with type 2 diabetes: Post hoc analysis of the SUSTAIN 6 and PIONEER 6 cardiovascular outcomes trials. Diabetes, Obesity and Metabolism, 25(8), 2398-2401. https://doi.org/10.1111/dom.15088

Vancouver

Verma S, Husain M, Madsen CM, Leiter LA, Kuhlman AB, Vilsbøll T o.a. Neutrophil to lymphocyte ratio predicts cardiovascular events in people with type 2 diabetes: Post hoc analysis of the SUSTAIN 6 and PIONEER 6 cardiovascular outcomes trials. Diabetes, Obesity and Metabolism. 2023;25(8):2398-2401. https://doi.org/10.1111/dom.15088

Author

Verma, Subodh ; Husain, Mansoor ; Madsen, Christian M. ; Leiter, Lawrence A. ; Kuhlman, Anja Birk ; Vilsbøll, Tina ; Rasmussen, Søren ; Libby, Peter. / Neutrophil to lymphocyte ratio predicts cardiovascular events in people with type 2 diabetes : Post hoc analysis of the SUSTAIN 6 and PIONEER 6 cardiovascular outcomes trials. I: Diabetes, Obesity and Metabolism. 2023 ; Bind 25, Nr. 8. s. 2398-2401.

Bibtex

@article{a16dcf17c67b41599595feb8976b7a85,
title = "Neutrophil to lymphocyte ratio predicts cardiovascular events in people with type 2 diabetes: Post hoc analysis of the SUSTAIN 6 and PIONEER 6 cardiovascular outcomes trials",
keywords = "antidiabetic drug, cardiovascular disease, GLP-1 analogue, randomized trial, type 2 diabetes",
author = "Subodh Verma and Mansoor Husain and Madsen, {Christian M.} and Leiter, {Lawrence A.} and Kuhlman, {Anja Birk} and Tina Vilsb{\o}ll and S{\o}ren Rasmussen and Peter Libby",
note = "Funding Information: The authors thank the participants involved in the SUSTAIN 6 and PIONEER 6 trials, the investigators and trial site staff. We also thank Sarah White from AXON Communications, for editorial assistance, funded by Novo Nordisk A/S. ",
year = "2023",
doi = "10.1111/dom.15088",
language = "English",
volume = "25",
pages = "2398--2401",
journal = "Diabetes, Obesity and Metabolism",
issn = "1462-8902",
publisher = "Wiley-Blackwell",
number = "8",

}

RIS

TY - JOUR

T1 - Neutrophil to lymphocyte ratio predicts cardiovascular events in people with type 2 diabetes

T2 - Post hoc analysis of the SUSTAIN 6 and PIONEER 6 cardiovascular outcomes trials

AU - Verma, Subodh

AU - Husain, Mansoor

AU - Madsen, Christian M.

AU - Leiter, Lawrence A.

AU - Kuhlman, Anja Birk

AU - Vilsbøll, Tina

AU - Rasmussen, Søren

AU - Libby, Peter

N1 - Funding Information: The authors thank the participants involved in the SUSTAIN 6 and PIONEER 6 trials, the investigators and trial site staff. We also thank Sarah White from AXON Communications, for editorial assistance, funded by Novo Nordisk A/S.

PY - 2023

Y1 - 2023

KW - antidiabetic drug

KW - cardiovascular disease

KW - GLP-1 analogue

KW - randomized trial

KW - type 2 diabetes

U2 - 10.1111/dom.15088

DO - 10.1111/dom.15088

M3 - Letter

C2 - 37046366

AN - SCOPUS:85158168737

VL - 25

SP - 2398

EP - 2401

JO - Diabetes, Obesity and Metabolism

JF - Diabetes, Obesity and Metabolism

SN - 1462-8902

IS - 8

ER -

ID: 365746829